copper-binding tripeptide

GHK-Cu

US: Not on the registerEU: Not on the registerUK: Not on the registerCA: Not on the registerAU: Status unknownCH: Not on the registerBR: Not on the registerRS: Not on the registerSG: Not on the registerTR: Not on the register

Answer

GHK-Cu is not authorised on any of the 10 registers read, and 1 of them holds no reading for it. Highest trial phase: Phase 4 (after approval). It has 3 registered trials, 2 of them running.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials3Trial register ClinicalTrials.gov

Running now2Trial register recruiting, active or enrolling

Results posted0Trial register with results on the register

Stopped early0%Trial register all peptides: 10%

3 trials by status

Trial register

Running 2Completed 1

ClinicalTrials.gov · read 2026-10-03 · 0 trials have posted results

Trials first submitted per year

Trial register

12023

22026

ClinicalTrials.gov first-submitted date, last 2 years · read 2026-10-03. 2026 is not complete.

Status by jurisdiction

World map

CAISNOUSUKEUUACNKRJPMXCHLIRSTRINTHBREGILSAAESGARZAAUNZ

Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown

Where	Status	Register	Read
United States	Not on the register	FDA, openfda	2026-10-03
European Union	Not on the register	EMA, ema	2026-08-31
United Kingdom	Not on the register	MHRA, uk-mhra	2026-09-03
Canada	Not on the register	Health Canada, ca-dpd	2026-09-03
Australia	Status unknown	TGA, au-artg	not read
Switzerland	Not on the register	Swissmedic, ch-swissmedic	2026-09-03
Brazil	Not on the register	ANVISA, br-anvisa	2026-09-03
Serbia	Not on the register	ALIMS, rs-alims	2026-09-03
Singapore	Not on the register	HSA, sg-hsa	2026-09-03
Turkey	Not on the register	TITCK, tr-titck	2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

CHANGE ALERTS

Get an email when this changes

One email when the status of GHK-Cu changes on the register. You confirm your address first.

REGISTERED TRIALS

3 trials, newest first

NCT07706361	Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults not yet recruiting participants · register updated 2026-07-15
NCT07437586	Topical GHK-Cu Gel for Acute Skin Wound Healing currently recruiting participants · register updated 2026-02-27
NCT05932732	Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of Al completed · register updated 2024-10-24

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.